Literature DB >> 11181864

Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia.

H Takenoshita1, M Shizuka-Ikeda, H Mitoma, S Song, Y Harigaya, Y Igeta, M Yaguchi, K Ishida, M Shoji, M Tanaka, H Mizusawa, K Okamoto.   

Abstract

Autoantibodies against glutamic acid decarboxylase (GAD) have been found in stiff-man syndrome, insulin dependent diabetes mellitus, and progressive cerebellar ataxia. A patient with progressive cerebellar ataxia is described who was positive for GAD autoantibodies, and had Sjögren's syndrome. Immunohistochemical studies using CSF and serum samples from the patient showed immunoreactivities in axon terminals of cerebellar GABAergic neurons. A whole cell patch clamp technique recording from rat cerebellar slices showed that the CSF, presumably through GAD autoantibodies, presynaptically inhibited GABAergic transmission. Intravenous administration of immunoglobulin failed to improve clinical symptoms and immunoreactivities examined after therapy. The findings suggest that GAD autoantibodies play a pathogenic part in reducing GABA release in in vitro slices.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181864      PMCID: PMC1737259          DOI: 10.1136/jnnp.70.3.386

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

1.  Cerebellar degeneration and polyglandular autoimmune syndrome with anti-glutamic acid decarboxylase antibodies.

Authors:  S Rüegg; M Stahl; M Bühlmann; A Dupont; P A Lyrer; R L Humbel; A J Steck
Journal:  J Neurol       Date:  2002-03       Impact factor: 4.849

Review 2.  Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes.

Authors:  Goran Rakocevic; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

3.  Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.

Authors:  Zoya Georgieva; Matthew Parton
Journal:  BMJ Case Rep       Date:  2014-01-13

Review 4.  Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  J Neural Transm (Vienna)       Date:  2017-07-08       Impact factor: 3.575

5.  GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.

Authors:  Yasushi Hosoi; Makiko Suzuki-Sakao; Tatsuhiro Terada; Takashi Konishi; Yasuomi Ouchi; Hiroaki Miyajima; Satoshi Kono
Journal:  J Neurol       Date:  2013-10-05       Impact factor: 4.849

Review 6.  GAD antibodies in neurological disorders - insights and challenges.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2020-05-26       Impact factor: 42.937

7.  Interactions of Human Autoantibodies with Hippocampal GABAergic Synaptic Transmission - Analyzing Antibody-Induced Effects ex vivo.

Authors:  Holger Haselmann; Luise Röpke; Christian Werner; Albrecht Kunze; Christian Geis
Journal:  Front Neurol       Date:  2015-06-11       Impact factor: 4.003

8.  Serum from a Patient with GAD65 Antibody-Associated Limbic Encephalitis Did Not Alter GABAergic Neurotransmission in Cultured Hippocampal Networks.

Authors:  Nelly Stemmler; Karin Rohleder; Michael P Malter; Guido Widman; Christian E Elger; Heinz Beck; Rainer Surges
Journal:  Front Neurol       Date:  2015-08-28       Impact factor: 4.003

9.  Excitability of the motor cortex in de novo patients with celiac disease.

Authors:  Giovanni Pennisi; Giuseppe Lanza; Salvatore Giuffrida; Luisa Vinciguerra; Valentina Puglisi; Mariagiovanna Cantone; Manuela Pennisi; Carmela Cinzia D'Agate; Pietro Naso; Giuseppe Aprile; Giulia Malaguarnera; Raffaele Ferri; Rita Bella
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

10.  Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.

Authors:  Thashi Chang; Haris Alexopoulos; Mary McMenamin; Alexander Carvajal-González; Sian K Alexander; Robert Deacon; Ferenc Erdelyi; Gabor Szabó; Szabó Gabor; Bethan Lang; Franz Blaes; Peter Brown; Angela Vincent
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.